Liver uptake of Biguanides in rats

Biomedicine and Pharmacotherapy

Volumn 65, Issue 6, 2011, Pages 451-455

  Sogame, Yoshihisa ^a   Kitamura, Atsushi ^a   Yabuki, Masashi ^a   Komuro, Setsuko ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Hepatic uptake; Metformin; Phenformin

Indexed keywords

CARBON 14; METFORMIN; PHENFORMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYOPRESERVATION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG UPTAKE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

ANIMALS; BIGUANIDES; BIOLOGICAL TRANSPORT, ACTIVE; BIOTRANSFORMATION; CELLS, CULTURED; HEPATOCYTES; HYPOGLYCEMIC AGENTS; LIVER; MALE; METFORMIN; PHENFORMIN; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; TISSUE DISTRIBUTION;

EID: 80052674889     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.022     Document Type: Article

References (24)

1. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:550-554.
2. Cusi K., Consoli A., DeFronzo R.A. Metabolic effects of metformin on glucose and lactate metabolism in non insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996, 81:4059-4067.
3. Prager R., Schernthaner G., Graf H. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabet Metab 1986, 12:346-350.
4. DeFronzo R.A., Barzilai N., Simonson D.C. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991, 73:1294-1301.
5. Ikeda T., Iwata K., Murakami H. Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol 2000, 59:887-890.
6. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
7. Jonker J.W., Schinkel A.H. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). JEPET 2004, 308:2-9.
8. Wright S.H. Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicol Appl Pharmacol 2005, 204:309-319.
9. Choi M.K., Jin Q.R., Jin H.E., Shim C.K., Cho D.Y., Shin J.G., et al. Effects of tetra-alkylammonium compounds with different affinities for organic cation transporters on the pharamacokinetics of metformin. Biopharm Drug Dispos 2007, 28:501-510.
10. Shu Y., Sheardown S.A., Brown C., Owen R.P., Zhang S., Castro R.A., et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007, 117:1422-1431.
11. Wang D.S., Jonker J.W., Kato Y., Kusuhara H., Schinkel A.H., Sugiyama Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. JPET 2002, 302:1-6.
12. Wang D.S., Kusuhara H., Kato Y., Jonker J.W., Schinkel A.H., Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003, 63:844-848.
13. Sogame Y., Kitamura A., Yabuki M., Komuro S. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes. Biopharm Drug Dispos 2009, 30:476-484.
14. Umehara K.I., Iwatsubo T., Noguchi K., Kamimura H. Functional involvement of organic cation transporter 1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats. Xenobiotica 2007, 37:818-831.
15. Yamazaki M., Tokui T., Ishigami M., Sugiyama Y. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system. Biopharm Drug Dispos 1996, 17:775-789.
16. Yamazaki M., Suzuki H., Hanano M., Tokui T., Komai T., Sugiyama Y. Na+-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 1993, 264:G36-G44.
17. Guest D., King L.J., Parke D.V. Metabolism of phenformin in the rat and guinea-pig. Xenobiotica 1979, 9:681-693.
18. Cairns S.A., Shalet S., Marshall A.J., Hartog M. A comparison of phenformin and metformin in the treatment of maturity onset diabetes. Diabet Metab 1977, 3:183-188.
19. Fletcher P., Hirji M.R., Kuhn S., Alexander L., Mucklow J.C. The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man. Br J Clin Pharmacol 1986, 21:691-699.
20. Owen M.R., Doran E., Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000, 348:607-614.
21. El-Mir M.Y., Nogueira V., Fontaine E., Averet N., Rigoulet M., Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000, 275:223-228.
22. Alkalay D., Khemani L., Wagner W.E., Bartlett M.F. Pharmacokinetics of phenformin in man. J Clin Pharmacol 1975, 15:446-448.
23. Oates N.S., Shah R.R., Idle J.R., Smith R.L. Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin Pharmacol Ther 1983, 34:827-834.
24. Pentikäinen P.J., Neuvonen P.J., Penttilä A. Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin 1979, 16:195-202.